• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Germany·Healthcare·0PMJ.L
Share

Siemens Healthineers AG Stocks

€ 34.83Last Updated 12.06.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

€ 44.90B

€ 34.83
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Siemens Healthineers AG, operating through its various subsidiaries, is dedicated to the development, production, and worldwide distribution of a comprehensive portfolio of diagnostic and therapeutic solutions for healthcare professionals. The company's operations are structured across four primary segments: Imaging, Diagnostics, Varian, and Advanced Therapies. Within the Imaging segment, customers access advanced technologies such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray systems, molecular imaging, and ultrasound equipment. The Diagnostics segment delivers a range of in-vitro diagnostic products and services, catering to laboratory, molecular, and point-of-care diagnostic needs, alongside specialized workflow solutions for laboratories and informatics tools. The Varian segment specializes in advanced cancer care technologies, providing a suite of solutions and services to oncology departments within hospitals and clinics. This includes optimized, technology-enabled workflows, comprehensive clinical and consulting services, and innovative digital applications designed for managing patient treatment and therapy pathways. For image-guided minimally invasive procedures in fields like cardiology, interventional radiology, and surgery, the Advanced Therapies segment offers specialized products. Its portfolio encompasses angiography systems, mobile C-arms, and an advanced robotic-assisted platform specifically engineered for endovascular coronary and peripheral vascular interventions. Beyond these core offerings, Siemens Healthineers also provides essential support services. These include equipment performance management, clinical education and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare facilities, complemented by consulting and digital health services. The company's corporate headquarters are situated in Erlangen, Germany, and it operates as a subsidiary of Siemens Aktiengesellschaft.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026